TheEdgeResearch
Home / Stocks / GEATF

Radiko Holdings Corp (GEATF)

OTC Healthcare Medical - Pharmaceuticals
$0.00 ▲ +0.00%
Market Cap
$4,453
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
-6.61
52-Wk Range
0.000001-0.00001
CEO
Pierluigi Paracchi
Country
US
Currency
USD

Radiko Holdings Corp operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Los Angeles, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $4,453. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -205.5%. Its beta of -6.61 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
-0.00
EV / EBITDA
-0.12
Gross margin
-31.0%
Operating margin
-203.0%
Net margin
-205.5%
Return on equity
Debt / equity
-0.83
Current ratio
0.25
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
22
IPO date
2017-11-08
Headquarters
Los Angeles, CA, US
About Radiko Holdings Corp

Radiko Holdings Corp., together with its subsidiaries, focuses on cannabis industries in the United States and internationally. The company also manufactures and distributes a range of cannabis infused edibles and tinctures under the La Vida Verde brand; a range of wholesale flower, packaged flower, pre-rolls, and concentrates under the Skunk Feather brand; a range of cannabis, infused, chocolates, and edible cannabis consumables gummies, and capsules under the name the Blank Brand; and supplements under the Baseline brand. The company was formerly known as International Cannabrands Inc. and changed its name to Radiko Holdings Corp. in July 2020. The company is headquartered in Des Moines, Washington.

Comparable companies

Radiko Holdings Corp is most often compared with the following Healthcare names:

CSTFDKSCERBBFITXFTEGGRCUINSOSLNXSTSNXBRAF
More research on GEATF
GEATF technical analysis GEATF TheEdge Score Compare against peers
Open full interactive analysis & DCF →